PDE9A and Dravet syndrome: In 2011, Lim et al. report a DR of 77.8% of DS pregnancies for this marker and a 5% FPR, demonstrating that U-PDE9A is an effective biomarker for the non-invasive diagnosis of DS during the first-trimester of pregnancy [57].